These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 8598592)
1. A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression. Mason BJ; Kocsis JH; Ritvo EC; Cutler RB JAMA; 1996 Mar; 275(10):761-7. PubMed ID: 8598592 [TBL] [Abstract][Full Text] [Related]
5. A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism. Kampman KM; Pettinati HM; Lynch KG; Whittingham T; Macfadden W; Dackis C; Tirado C; Oslin DW; Sparkman T; O'Brien CP J Clin Psychopharmacol; 2007 Aug; 27(4):344-51. PubMed ID: 17632217 [TBL] [Abstract][Full Text] [Related]
6. Fluoxetine versus placebo in depressed alcoholic cocaine abusers. Cornelius JR; Salloum IM; Thase ME; Haskett RF; Daley DC; Jones-Barlock A; Upsher C; Perel JM Psychopharmacol Bull; 1998; 34(1):117-21. PubMed ID: 9564208 [TBL] [Abstract][Full Text] [Related]
7. Lithium treatment of depressed and nondepressed alcoholics. Dorus W; Ostrow DG; Anton R; Cushman P; Collins JF; Schaefer M; Charles HL; Desai P; Hayashida M; Malkerneker U JAMA; 1989 Sep 22-29; 262(12):1646-52. PubMed ID: 2504944 [TBL] [Abstract][Full Text] [Related]
8. Alprazolam: an antidepressant? Alprazolam, desipramine, and an alprazolam-desipramine combination in the treatment of adult depressed outpatients. Fawcett J; Edwards JH; Kravitz HM; Jeffriess H J Clin Psychopharmacol; 1987 Oct; 7(5):295-310. PubMed ID: 3316312 [TBL] [Abstract][Full Text] [Related]
9. Regional brain metabolic correlates of alpha-methylparatyrosine-induced depressive symptoms: implications for the neural circuitry of depression. Bremner JD; Vythilingam M; Ng CK; Vermetten E; Nazeer A; Oren DA; Berman RM; Charney DS JAMA; 2003 Jun; 289(23):3125-34. PubMed ID: 12813118 [TBL] [Abstract][Full Text] [Related]
10. Lithium and desipramine versus desipramine alone in the treatment of severe major depression: a preliminary study. Cappiello A; McDougle CJ; Delgado PL; Malison RT; Jatlow P; Charney DS; Heninger GR; Price LH Int Clin Psychopharmacol; 1998 Sep; 13(5):191-8. PubMed ID: 9817623 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness and tolerability of mirtazapine and amitriptyline in alcoholic patients with co-morbid depressive disorder: a randomized, double-blind study. Altintoprak AE; Zorlu N; Coskunol H; Akdeniz F; Kitapcioglu G Hum Psychopharmacol; 2008 Jun; 23(4):313-9. PubMed ID: 18327889 [TBL] [Abstract][Full Text] [Related]
12. Antidepressant pharmacotherapy of depression associated with multiple sclerosis. Schiffer RB; Wineman NM Am J Psychiatry; 1990 Nov; 147(11):1493-7. PubMed ID: 2221162 [TBL] [Abstract][Full Text] [Related]
13. Depression predicts higher rates of heroin use on desipramine with buprenorphine than with methadone. Kosten T; Falcioni J; Oliveto A; Feingold A Am J Addict; 2004; 13(2):191-201. PubMed ID: 15204669 [TBL] [Abstract][Full Text] [Related]
14. Effects of electroconvulsive therapy and desipramine on neuroendocrine responses to the clonidine challenge test. Coote M; Wilkins A; Werstiuk ES; Steiner M J Psychiatry Neurosci; 1998 May; 23(3):172-8. PubMed ID: 9595891 [TBL] [Abstract][Full Text] [Related]
15. Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics. Kranzler HR; Burleson JA; Korner P; Del Boca FK; Bohn MJ; Brown J; Liebowitz N Am J Psychiatry; 1995 Mar; 152(3):391-7. PubMed ID: 7864265 [TBL] [Abstract][Full Text] [Related]
16. A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence. Anton RF; Kranzler H; Breder C; Marcus RN; Carson WH; Han J J Clin Psychopharmacol; 2008 Feb; 28(1):5-12. PubMed ID: 18204334 [TBL] [Abstract][Full Text] [Related]
17. Comorbid major depressive disorder as a prognostic factor in cocaine-abusing buprenorphine-maintained patients treated with desipramine and contingency management. Gonzalez G; Feingold A; Oliveto A; Gonsai K; Kosten TR Am J Drug Alcohol Abuse; 2003 Aug; 29(3):497-514. PubMed ID: 14510037 [TBL] [Abstract][Full Text] [Related]
18. Fluvoxamine in the treatment of tricyclic-resistant depression. White K; Wykoff W; Tynes LL; Schneider L; Zemansky M Psychiatr J Univ Ott; 1990 Sep; 15(3):156-8. PubMed ID: 2123039 [TBL] [Abstract][Full Text] [Related]
19. A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer. Holland JC; Romano SJ; Heiligenstein JH; Tepner RG; Wilson MG Psychooncology; 1998; 7(4):291-300. PubMed ID: 9741068 [TBL] [Abstract][Full Text] [Related]
20. Concurrent treatment of nonresistant major depression with desipramine and lithium: a double-blind, placebo-controlled study. Bloch M; Schwartzman Y; Bonne O; Lerer B J Clin Psychopharmacol; 1997 Feb; 17(1):44-8. PubMed ID: 9004056 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]